Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

Reuters May 31, 2020 20:01:29 IST
Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients

Bengaluru: Drugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesilate in COVID-19 patients.

"Nafamostat (has been) identified as a potential candidate for COVID-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate Research, Germany," the company said in a statement.

Click here to follow LIVE updates on coronavirus outbreak

The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020.

Shares of Sun Pharma rose 5 percent intraday on Friday after receiving approval from the Indian drug regulator for clinical trial of its drug on COVID-19 patients.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

As world waits for COVID-19 vaccine, India must use time to build robust immunisation plan, delivery system for last-mile reach
India

As world waits for COVID-19 vaccine, India must use time to build robust immunisation plan, delivery system for last-mile reach

Right from selecting the strategy for delivery of COVID-19 vaccine to recruiting a large volunteer staff, every tool must be analysed from the perspective of India’s unique public health system and its capabilities

India reports 14,821 new COVID-19 patients, 445 deaths in past 24 hours; total case count crosses 4.2 lakh with toll now at 13,699
India

India reports 14,821 new COVID-19 patients, 445 deaths in past 24 hours; total case count crosses 4.2 lakh with toll now at 13,699

India on Monday added 14,821 new COVID-19 cases pushing the infection tally to 4,25,282, while the death toll rose to 13,699 with 445 new fatalities, according to Union Health Ministry data.

LaLiga: Fans to be asked to wear face masks, avoid hugs and high-fives when they're eventually allowed in stands
Sports

LaLiga: Fans to be asked to wear face masks, avoid hugs and high-fives when they're eventually allowed in stands

Fans will have their temperature checked and will need to wear face masks when they are eventually allowed back into football stadiums in Spain, according to protocol guidelines sent to clubs.